Drug Database
B02 ANTIHEMORRHAGICS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- B02AA02 tranexamic acid
- B02AB01 aprotinin
- B02AB02 alfa1 antitrypsin
- B02BA01 phytomenadione
- B02BA02 menadione
- B02BB01 fibrinogen, human
- B02BC30 combinations
- B02BD01 coagulation factor IX, II, VII and X in combination
- B02BD02 coagulation factor VIII
- B02BD03 factor VIII inhibitor bypassing activity
- B02BD04 coagulation factor IX
- B02BD06 von Willebrand factor and coagulation factor VIII in combination
- B02BD07 coagulation factor XIII
- B02BD08 coagulation factor VIIa
- B02BD10 von Willebrand factor
- B02BD11 catridecacog
- B02BD13 coagulation factor X
- B02BD14 susoctocog alfa
- B02BD16 etranacogene dezaparvovec
- B02BX04 romiplostim
- B02BX05 eltrombopag
- B02BX06 emicizumab
- B02BX07 lusutrombopag
- B02BX08 avatrombopag
- B02BX09 fostamatinib
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).